5-hydroxymethylcytosine has been researched along with Cirrhosis, Liver in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Lin, XY | 1 |
| Feng, YQ; Huang, JT; Huang, W; Liu, SM; Liu, YJ; Qi, JH; Shen, F; Yuan, BF; Zhou, X | 1 |
2 other study(ies) available for 5-hydroxymethylcytosine and Cirrhosis, Liver
| Article | Year |
|---|---|
Are the 5-hydroxymethylcytosine-based wd-scores really superior over α-fetoprotein for the early diagnosis of hepatocellular carcinoma?
Topics: 5-Methylcytosine; alpha-Fetoproteins; Carcinoma, Hepatocellular; Cell-Free Nucleic Acids; Early Diagnosis; Humans; Liver Cirrhosis; Liver Neoplasms | 2020 |
Association of 5-methylcytosine and 5-hydroxymethylcytosine with mitochondrial DNA content and clinical and biochemical parameters in hepatocellular carcinoma.
Topics: 5-Methylcytosine; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Cytosine; DNA, Mitochondrial; Female; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Risk Factors; Tumor Burden; Young Adult | 2013 |